Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar. This occurs in roughly one-quarter to one-half of these patients and can lead to serious ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar. This occurs in roughly one-quarter to one-half of these patients, leading to serious ...

Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in ...

An algorithm paired with a continuous glucose monitor can help people living with type 2 diabetes better manage their condition by recommending insulin-dose adjustments. This is the claim of ...

To address this, researchers created a self-adjusting subcutaneous insulin algorithm (SQIA) for use at UCSF’s San Francisco hospitals. A new study shows that their SQIA reduces rates of severe ...

A Tandem pump built for (Type) 2: President and CEO John Sheridan said the company's expansion was a "natural evolution" of its mission. (Tandem Diabetes Care) Tandem Diabetes Care has secured a new ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

PALO ALTO, Calif., April 11, 2023 /PRNewswire/ -- Glooko, Inc., announced today a new Global partnership with Hedia, integrating its technology into Glooko's diabetes management platforms for ...

Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be ...

糖尿病には複数の種類があり、そのうちの1つが「1型糖尿病」です。1型糖尿病は、すい臓のβ細胞が破壊されてインスリンが出なくなることで慢性的な高血糖状態になり、糖尿病を発症します。1型糖尿病の対処には、ペン型注射器などを用いた体内への ...